Status:
UNKNOWN
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
Brief Summary
RATIONALE: Studying samples of tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURP...
Detailed Description
OBJECTIVES: * Prospectively obtain specimens required for diagnostic review and molecular characterization ensuring eligibility for CALGB Leukemia Committee Clinical trials (for clinical trials desig...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically confirmed acute myeloid leukemia (AML)
- Tissue samples from previously untreated patients with AML considered for enrollment onto ongoing and future CALGB treatment protocols
- AML tissue samples from companion Leukemia Tissue Bank protocol CALGB-9665 and the companion cytogenetic protocol CALGB-8461
- AML diagnostic bone marrow and/or blood samples from patients enrolled on CLB-9720, CLB-9621 (all cytogenetic subtypes), and CALGB-19808 (abnormal cytogenetics only)
Exclusion
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
529 Patients enrolled
Trial Details
Trial ID
NCT00900224
Start Date
June 1 2008
Last Update
August 31 2023
Active Locations (77)
Enter a location and click search to find clinical trials sorted by distance.
1
Camino Medical Group - Treatment Center
Mountain View, California, United States, 94040
2
Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States, 19958
3
CCOP - Christiana Care Health Services
Newark, Delaware, United States, 19713
4
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia, United States, 20007